Human immunodeficiency virus, type 1 protease substrate specificity is limited by interactions between substrate amino acids bound in adjacent enzyme subsites

被引:0
|
作者
Ridky, TW
Cameron, CE
Cameron, J
Leis, J
Copeland, T
Wlodawer, A
Weber, IT
Harrison, RW
机构
[1] CASE WESTERN RESERVE UNIV,SCH MED,CLEVELAND,OH 44106
[2] NCI,FREDERICK CANC RES & DEV CTR,ABL BASIC RES PROGRAM,FREDERICK,MD 21702
[3] THOMAS JEFFERSON UNIV,JEFFERSON CANC INST,PHILADELPHIA,PA 19107
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The specificity of the retroviral protease is determined by the ability of substrate amino acid side chains to bind into eight individual subsites within the enzyme, Although the subsites are able to act somewhat independently in selection of amino acid side chains that fit into each pocket, significant interactions exist between individual subsites that substantially limit the number of cleavable amino acid sequences, The substrate peptide binds within the enzyme in an extended anti-parallel beta sheet conformation with substrate amino acid side chains adjacent in the linear sequence extending in opposite directions in the enzyme-substrate complex, From this geometry, we have defined both cis and trans steric interactions, which have been characterized by a steady state kinetic analysis of human immunodeficiency virus, type-1 protease using a series of peptide substrates that are derivatives of the avian leukosis/sarcoma virus nucleocapsid-protease cleavage site, These peptides contain both single and double amino acid substitutions in seven positions of the minimum length substrate required by the retroviral protease for specific and efficient cleavage, Steady state kinetic data from the single amino acid substituted peptides were used to predict effects on protease-catalyzed cleavage of corresponding double substituted peptide substrates, The calculated Gibbs' free energy changes were compared with actual experimental values in order to determine how the fit of a substrate amino acid in one subsite influences the fit of amino acids in adjacent subsites, Analysis of these data shows that substrate specificity is limited by steric interactions between pairs of enzyme subsites, Moreover, certain enzyme subsites are relatively tolerant of substitutions in the substrate and exert little effect on adjacent subsites, whereas others are more restrictive and have marked influence on adjacent cis and trans subsites.
引用
收藏
页码:4709 / 4717
页数:9
相关论文
共 50 条
  • [21] Enzyme Kinetics Studies of Spin-Labeled Active Human Immunodeficiency Virus Type 1 protease
    D'Amore, Peter W.
    BIOPHYSICAL JOURNAL, 2011, 100 (03) : 220 - 220
  • [22] Association of a novel human immunodeficiency virus type 1 protease substrate cleft mutation, L23I, with protease inhibitor therapy and in vitro drug resistance
    Johnston, E
    Winters, MA
    Rhee, SY
    Merigan, TC
    Schiffer, CA
    Shafer, RW
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (12) : 4864 - 4868
  • [23] BIDIRECTIONAL INTERACTIONS BETWEEN HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 AND CYTOMEGALO-VIRUS
    SKOLNIK, PR
    KOSLOFF, BR
    HIRSCH, MS
    JOURNAL OF INFECTIOUS DISEASES, 1988, 157 (03): : 508 - 514
  • [24] Characterizing the protonation states of the catalytic residues in apo and substrate-bound human T-cell leukemia virus type 1 protease
    Ma, Shuhua
    Vogt, Kimberly A.
    Petrillo, Natalie
    Ruhoff, Alyce J.
    COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2015, 56 : 61 - 70
  • [25] Association between secondary mutations in human immunodeficiency virus type 1 protease and therapeutic outcome
    Frater, J
    Dunn, D
    Weber, JN
    McClure, MO
    JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (09): : 1376 - 1376
  • [26] ANALYSIS OF SUBSTRATE INTERACTIONS OF THE ROUS-SARCOMA VIRUS WILD-TYPE AND MUTANT PROTEASES AND HUMAN IMMUNODEFICIENCY VIRUS-1 PROTEASE USING A SET OF SYSTEMATICALLY ALTERED PEPTIDE-SUBSTRATES
    GRINDE, B
    CAMERON, CE
    LEIS, J
    WEBER, IT
    WLODAWER, A
    BURSTEIN, H
    SKALKA, AM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1992, 267 (14) : 9491 - 9498
  • [27] Antagonism between human immunodeficiency virus type 1 protease inhibitors indinavir and saquinavir in vitro
    Merrill, DP
    Manion, DJ
    Chou, TC
    Hirsch, MS
    JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (01): : 265 - 268
  • [28] SUBSTRATE-INHIBITION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE
    FURMAN, PA
    PAINTER, G
    WILSON, JE
    CHENG, N
    HOPKINS, S
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (14) : 6013 - 6017
  • [29] Interactions between human immunodeficiency virus type 1 and vaccinia virus in human lymphoid tissue ex vivo
    Vanpouille, Christophe
    Bioncotto, Angelique
    Lisco, Andrea
    Brichacek, Beda
    JOURNAL OF VIROLOGY, 2007, 81 (22) : 12458 - 12464
  • [30] Narrow substrate specificity and sensitivity toward ligand-binding site mutations of human T-cell leukemia virus type 1 protease
    Kádas, J
    Weber, IT
    Bagossi, P
    Miklóssy, G
    Boross, P
    Oroszlan, S
    Tözsér, J
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (26) : 27148 - 27157